Mobile app
DeviceMedical device for improving emotion dysregulation
NCT Number: NCT04519008
To assess the effectiveness and security of a mobile App (beta version) for self-managing emotion dysregulation in a pragmatic randomized controlled trial with 80 adolescents with attention-deficit/hyperactivity disorder comparing 40 patients with treatment as usual (TAU) with 40 patients with TAU plus the mobile App
Trial opening soon.
Get Notified14 year–17 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Medical device for improving emotion dysregulation
Bimonthly individual psychotherapy and psychostimulant medications
Time frame: 9 months
Severity of emotional dysregulation as measured by a single score from the The DERS (Difficulties in Emotion Regulation Scale) (range: 0-88; the higher the score, the more severe the emotion dysregulation severity).
Time frame: 9.months
Severity of smartphone addiction as measured by the Spanish version of the The Smartphone Addiction Scale (SAS) (range: 10-60; the higher the score, the more severe the smartphone addiction severity).
Contact information is provided by the study sponsor or research team.
Consorci Sanitari del Maresme
Other
Effectiveness and Security Testing of a Mobile App (B·RIGHT) for Adolescents With Attention-Deficit/Hyperactivity Disorder and Emotion Dysregulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07442058
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Providence, Rhode Island, United States
View Trial DetailsNCT06797570
ADD, ADHD
View Trial DetailsNCT00001246
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Bethesda, Maryland, United States
View Trial DetailsNCT01876524
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Cartagena, Murcia, Spain
View Trial Details